52
Registered trials
10
Recruiting
23
Unique sponsors
23
Unique IMPs
44
Commercial trials
Drug classes (ATC)
—
ATC code not specified
41
A
Gastroenterology (ATC A)
10
B
Haematology (ATC B)
2
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Unknown / small molecule
20 substances
GLP-1 receptor agonist
2 substances
Antiplatelet / NSAID
1 substance
Phase III:
20
Phase II:
5
Phase I/II:
1
Phase IV:
3
Phase I:
3
Phase I (Other):
19
Other:
1
Phase III
20 trials-
EndedAmgen Inc. CommercialMARIDEBART CAFRAGLUTIDE
-
EndedAmgen Inc. CommercialMARIDEBART CAFRAGLUTIDE
-
EndedBoehringer Ingelheim International GmbH CommercialBI 456906; SURVODUTIDE
-
EndedBoehringer Ingelheim International GmbH CommercialBI 456906; SURVODUTIDE
-
EndedBoehringer Ingelheim International GmbH CommercialBI 456906; SURVODUTIDE
-
RecruitingF. Hoffmann-La Roche AG CommercialN-[2-(3-CYANO-5-FLUOROPHENYL)-2-METHYL-1-OXOPROPYL]-BETA-ALANYL-L-ALPHA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALPHA-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYLALANYL-L-LEUCYL-L-ALPHA-ASPARTYL-L-LYSYL-L-ISOLEUCYL-L-ALANYL-L-GLUTAMINYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL]-L-LYSYL-L-ALANYL-L-PHENYLALANYL-L-VALYL-L-GLUTAMINYL-L-TRYPTOPHYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERINAMIDE
-
RecruitingF. Hoffmann-La Roche AG CommercialN-[2-(3-CYANO-5-FLUOROPHENYL)-2-METHYL-1-OXOPROPYL]-BETA-ALANYL-L-ALPHA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALPHA-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYLALANYL-L-LEUCYL-L-ALPHA-ASPARTYL-L-LYSYL-L-ISOLEUCYL-L-ALANYL-L-GLUTAMINYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL-2-[2-(2-AMINOETHOXY)ETHOXY]ACETYL]-L-LYSYL-L-ALANYL-L-PHENYLALANYL-L-VALYL-L-GLUTAMINYL-L-TRYPTOPHYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERINAMIDE
-
PendingKailera Therapeutics Inc. CommercialTYROSYL-2-AMINOISOBUTYRYL-GLUTAMYL-GLYCYL-THREONYL-PHENYLALANYLTHREONYL-SERYL-ASPARTATE-TYROSYL-SERYL-ISOLEUCYL-TYROSYL-LYSYL([2-[2- AMINOETHOXY]ETHOXY]ACETYL-[2-[2-AMINOETHOXY]ETHOXY]ACETYL-GAMMA-GLUTAMYL-EICOSANOYL)-GLUTAMYL-LYSYL-ISOLEUCYL-ALANYL-ALANYL-GLUTAMINE-GLUTAMYL-PHENYLALANYL-VALYL-ASPARAGINE-CHROMYL-LEUCYL-LEUCYL-ALANYL-GLYCYL-GLYCYL-PROLYL-SERYL-SERYL-GLYCYL-ALANYL-PROLYL-PROLYL-PROLYL-SERYL AMIDE
-
PendingKailera Therapeutics Inc. CommercialTYROSYL-2-AMINOISOBUTYRYL-GLUTAMYL-GLYCYL-THREONYL-PHENYLALANYLTHREONYL-SERYL-ASPARTATE-TYROSYL-SERYL-ISOLEUCYL-TYROSYL-LYSYL([2-[2- AMINOETHOXY]ETHOXY]ACETYL-[2-[2-AMINOETHOXY]ETHOXY]ACETYL-GAMMA-GLUTAMYL-EICOSANOYL)-GLUTAMYL-LYSYL-ISOLEUCYL-ALANYL-ALANYL-GLUTAMINE-GLUTAMYL-PHENYLALANYL-VALYL-ASPARAGINE-CHROMYL-LEUCYL-LEUCYL-ALANYL-GLYCYL-GLYCYL-PROLYL-SERYL-SERYL-GLYCYL-ALANYL-PROLYL-PROLYL-PROLYL-SERYL AMIDE
-
PendingKailera Therapeutics Inc. CommercialSEMAGLUTIDE; TYROSYL-2-AMINOISOBUTYRYL-GLUTAMYL-GLYCYL-THREONYL-PHENYLALANYLTHREONYL-SERYL-ASPARTATE-TYROSYL-SERYL-ISOLEUCYL-TYROSYL-LYSYL([2-[2- AMINOETHOXY]ETHOXY]ACETYL-[2-[2-AMINOETHOXY]ETHOXY]ACETYL-GAMMA-GLUTAMYL-EICOSANOYL)-GLUTAMYL-LYSYL-ISOLEUCYL-ALANYL-ALANYL-GLUTAMINE-GLUTAMYL-PHENYLALANYL-VALYL-ASPARAGINE-CHROMYL-LEUCYL-LEUCYL-ALANYL-GLYCYL-GLYCYL-PROLYL-SERYL-SERYL-GLYCYL-ALANYL-PROLYL-PROLYL-PROLYL-SERYL AMIDE
-
RecruitingMetsera Inc. CommercialL-PHENYLALANYL-2-METHYLALANYL-L-ALFA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALFA-ASPARTYL-L-VALYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-LEUCYL-L-ALFA-GLUTAMYL-L-ALFA-GLUTAMYL-L-LYSYL-L-ARGINYL-L-VALYL-L-ARGINYL-L-ALFA-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-ALFA-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-L-LYSYL-L-GLUTAMINYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-PROLYL-L-PROLYLGLYCYL-L-LYSYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL]-L-LYSINE
-
RecruitingMetsera Inc. CommercialL-PHENYLALANYL-2-METHYLALANYL-L-ALFA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALFA-ASPARTYL-L-VALYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-LEUCYL-L-ALFA-GLUTAMYL-L-ALFA-GLUTAMYL-L-LYSYL-L-ARGINYL-L-VALYL-L-ARGINYL-L-ALFA-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-ALFA-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-L-LYSYL-L-GLUTAMINYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-PROLYL-L-PROLYLGLYCYL-L-LYSYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL]-L-LYSINE
-
EndedNovo Nordisk A/S CommercialSEMAGLUTIDE
-
EndedNovo Nordisk A/S CommercialIMP not specified
-
EndedNovo Nordisk A/S CommercialLIRAGLUTIDE
-
EndedNovo Nordisk A/S CommercialCAGRILINTIDE, SEMAGLUTIDE
-
EndedNovo Nordisk A/S CommercialCAGRILINTIDE, SEMAGLUTIDE
-
PendingCasa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali AcademicACETYLSALICYLIC ACID; CLOPIDOGREL; SEMAGLUTIDE
-
RecruitingHospices Civils De Lyon AcademicCOLECALCIFEROL
-
PendingInstitut Klinicke A Experimentalni Mediciny AcademicIMP not specified
Phase II
5 trials-
EndedAmgen Inc. CommercialMARIDEBART CAFRAGLUTIDE
-
EndedF. Hoffmann-La Roche AG CommercialHUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN LATENT MYOSTATIN; TIRZEPATIDE
-
EndedNovo Nordisk A/S CommercialCAGRILINTIDE; CAGRILINTIDE, SEMAGLUTIDE; SEMAGLUTIDE
-
EndedPfizer Inc. CommercialLIRAGLUTIDE; PF-07976016-87
-
RecruitingRegion Hovedstaden AcademicSEMAGLUTIDE
Phase I/II
1 trial-
EndedAstraZeneca AB CommercialAZD6234; AZD9550
Phase IV
3 trials-
HaltedInstitut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre AcademicDEXMEDETOMIDINE; KETAMINE HYDROCHLORIDE; MAGNESIUM SULFATE HEPTAHYDRATE
-
EndedRegion Midtjylland AcademicSEMAGLUTIDE
-
EndedRijnstate Ziekenhuis Stichting AcademicSEMAGLUTIDE
Phase I
3 trials-
EndedCamurus AB CommercialIMP not specified
-
RecruitingCorteria Pharmaceuticals CommercialIMP not specified
-
EndedResalis Therapeutics S.r.l. CommercialIMP not specified
Phase I (Other)
19 trials-
EndedBoehringer Ingelheim International GmbH CommercialIMP not specified
-
RecruitingF. Hoffmann-La Roche AG CommercialIMP not specified
-
PendingF. Hoffmann-La Roche AG CommercialIMP not specified
-
PendingF. Hoffmann-La Roche AG CommercialIMP not specified
-
EndedF. Hoffmann-La Roche AG CommercialIMP not specified
-
RecruitingF. Hoffmann-La Roche AG CommercialIMP not specified
-
EndedF. Hoffmann-La Roche AG CommercialIMP not specified
-
RecruitingF. Hoffmann-La Roche AG CommercialIMP not specified
-
EndedGenentech Inc. CommercialIMP not specified
-
EndedGenentech Inc. CommercialIMP not specified
-
EndedNovo Nordisk A/S CommercialIMP not specified
-
EndedNovo Nordisk A/S CommercialIMP not specified
-
EndedNovo Nordisk A/S CommercialIMP not specified
-
EndedPfizer Inc. CommercialIMP not specified
-
EndedPfizer Inc. CommercialIMP not specified
-
EndedRose Pharma Inc. CommercialIMP not specified
-
EndedZealand Pharma A/S CommercialIMP not specified
-
EndedZealand Pharma A/S CommercialIMP not specified
-
EndedPauls Stradins Clinical University Hospital AcademicIMP not specified
Other
1 trial-
EndedEmpros Pharma AB CommercialACARBOSE, ORLISTAT; ORLISTAT
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| F. Hoffmann-La Roche AG | Commercial | 10 | Phase I (Other), Phase II, Phase III | 5 |
| Novo Nordisk A/S | Commercial | 9 | Phase I (Other), Phase II, Phase III | 0 |
| Boehringer Ingelheim International GmbH | Commercial | 4 | Phase I (Other), Phase III | 0 |
| Pfizer Inc. | Commercial | 3 | Phase I (Other), Phase II | 0 |
| Amgen Inc. | Commercial | 3 | Phase II, Phase III | 0 |
| Kailera Therapeutics Inc. | Commercial | 3 | Phase III | 0 |
| Genentech Inc. | Commercial | 2 | Phase I (Other) | 0 |
| Zealand Pharma A/S | Commercial | 2 | Phase I (Other) | 0 |
| Metsera Inc. | Commercial | 2 | Phase III | 2 |
| Camurus AB | Commercial | 1 | Phase I | 0 |
| Corteria Pharmaceuticals | Commercial | 1 | Phase I | 1 |
| Resalis Therapeutics S.r.l. | Commercial | 1 | Phase I | 0 |
| Empros Pharma AB | Commercial | 1 | Other | 0 |
| Rose Pharma Inc. | Commercial | 1 | Phase I (Other) | 0 |
| AstraZeneca AB | Commercial | 1 | Phase I/II | 0 |
| Pauls Stradins Clinical University Hospital | Academic | 1 | Phase I (Other) | 0 |
| Region Hovedstaden | Academic | 1 | Phase II | 1 |
| Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali | Academic | 1 | Phase III | 0 |
| Hospices Civils De Lyon | Academic | 1 | Phase III | 1 |
| Institut Klinicke A Experimentalni Mediciny | Academic | 1 | Phase III | 0 |
New trials by year
2021
1
2022
1
2023
7
2024
14
2025
14
2026
7